Empresa Innovita Biological Technology Co., Ltd.
Acciones
688253
CNE100005Q14
Equipo médico, suministros y distribución
Precio de cierre
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
42,1 CNY | -5,96 % | +15,88 % | +68,33 % |
Resumen de negocios
Número de empleados: 404
Ventas por actividad
CNY en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Respiratory Tract Series - Non-COVID-19 Products
84,8
%
| - | - | 405 | 84,8 % | - |
Respiratory Tract Series - COVID-19 Products
12,2
%
| - | - | 58 | 12,2 % | - |
Other Series
2,0
%
| 15 | 3,4 % | 10 | 2,0 % | -35,97 % |
Eugenics and Nurturing Series
0,9
%
| 4 | 0,9 % | 4 | 0,9 % | +8,31 % |
Point-of-care Testing Diagnostic Instrument
0,1
%
| 0 | 0,0 % | 1 | 0,1 % | +200,00 % |
Ventas por región
CNY en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
China
97,3
%
| 421 | 94,3 % | 465 | 97,3 % | +10,45 % |
Overseas (including Hong Kong, Macau and Taiwan)
2,7
%
| 26 | 5,7 % | 13 | 2,7 % | -49,12 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Xiu Jie Zhang
FOU | Founder | 53 | 06/02/06 |
Xiu Juan Zhao
DFI | Director of Finance/CFO | 50 | 01/10/16 |
Song Ling Li
CHM | Chairman | 43 | 01/10/13 |
Ting You Chen
CTO | Chief Tech/Sci/R&D Officer | 51 | 01/04/06 |
Xiao Gang Zhang
BRD | Director/Board Member | 60 | 01/09/08 |
Yu Heng He
IRC | Investor Relations Contact | 28 | - |
Fu Kang Chen
SEC | Corporate Secretary | 40 | 01/10/19 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Tian Long Hu
BRD | Director/Board Member | 47 | 09/11/20 |
Jian Sun
BRD | Director/Board Member | 42 | 09/11/20 |
Yi Lin
BRD | Director/Board Member | 55 | 01/12/19 |
Guan Mu Dong
BRD | Director/Board Member | 72 | 09/11/20 |
Feng Guang Ye
CHM | Chairman | 39 | 01/11/15 |
Xiu Jie Zhang
FOU | Founder | 53 | 06/02/06 |
Xiao Gang Zhang
BRD | Director/Board Member | 60 | 01/09/08 |
Ting You Chen
CTO | Chief Tech/Sci/R&D Officer | 51 | 01/04/06 |
Song Ling Li
CHM | Chairman | 43 | 01/10/13 |
Xiu Juan Zhao
DFI | Director of Finance/CFO | 50 | 01/10/16 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 136 060 816 | 50 125 833 ( 36,84 %) | 0 | 36,84 % |
Información de la empresa
Innovita Biological Technology Co., Ltd.
1/F-2/F, Building 6 1 Haiying Road
100071, Beijing
+
http://www.innovita.com.cnSector
Ventas por actividad
Ventas por región
Varia. 1 de ene. | Capi. | |
---|---|---|
+68,33 % | 844 M | |
-1,29 % | 12,64 mil M | |
-0,47 % | 8370,26 M | |
+5,68 % | 5365,79 M | |
+22,97 % | 5260,83 M | |
-2,03 % | 4579,47 M | |
-53,54 % | 3159,11 M | |
+19,30 % | 2890,59 M | |
-8,42 % | 2220,65 M | |
-3,55 % | 1909,2 M |
- Bolsa de valores
- Acciones
- Acción 688253
- Empresa Innovita Biological Technology Co., Ltd.